COVAX | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

79 results for “COVAX”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

1,404 participants · First posted Oct 15, 2021

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

32 participants · First posted Jun 11, 2020

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

1,133 participants · First posted Mar 10, 2021

COVAXIN in a Pediatric Cohort

525 participants · First posted Jun 9, 2021

COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

539 participants · First posted Mar 3, 2021

Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

600 participants · First posted May 28, 2021

No Longer Available

Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older

First posted Sep 15, 2022

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

326 participants · First posted Dec 2, 2021

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers

3,160 participants · First posted Aug 31, 2022

BBV152/BBV154 Heterologus Prime-Boost Study

608 participants · First posted Dec 7, 2022

Page 1 of 3